Medical News

RSS

New text messaging program to manage diabetes

D.C. Chartered Health Plan, Inc., the oldest Medicaid managed care organization in the District of Columbia, is launching a new text messaging program for 50 of its members to help them better manage diabetes, which requires regular care to avoid costly complications.

9 Apr 2012

Blog posts respond to Melinda Gates' TEDxChange presentation

The Bill & Melinda Gates Foundation's "Impatient Optimists" blog published several posts in response to the TEDxChange: "The Big Picture" presentation delivered by Melinda Gates, co-chair of the foundation, in Berlin on Thursday.

9 Apr 2012

Chemotherapy based on individual genomes and genomes of tumors

The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.

9 Apr 2012

Idaho's adoption of NPLEx to block illegal methamphetamine sales receives praise

The Consumer Healthcare Products Association (CHPA) today applauded Idaho Governor C.L. "Butch" Otter for signing into law real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx) which allows check-out clerks to block illegal pseudoephedrine purchases right at the point of sale and provides law enforcement with valuable criminal data up to the minute.

9 Apr 2012

A step closer to correcting unhealthy gene mutations with diet

Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS.

9 Apr 2012

States count health law dollars, brace for back-ups if overhaul struck down

In health law implementation news, Iowa gets federal grants for home care workers to visit families with children while Minnesota lawmakers brace for losing Medicaid dollars.

9 Apr 2012

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

Bioness Inc. today announced the initiation of a study to evaluate the safety and effectiveness of the company's StimRouter Neuromodulation System for those suffering from chronic peripheral nerve pain. This prospective, multi-center, randomized, double-blinded, partial crossover study will enroll 126 patients at up to 10 study sites throughout the United States.

9 Apr 2012

Japanese MHLW approves Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System

Abbott today announced it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

9 Apr 2012

Five significant genetic associations for hypothyroidism found

Using its unique online research platform, 23andMe, a leading personal genetics company, has found five significant genetic associations for hypothyroidism in the largest known genome-wide association study of hypothyroidism conducted to date. The details of the study are now available online in the journal PLoS ONE.

9 Apr 2012

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN

Winston Pharmaceuticals, Inc.,, announced that the National Institutes of Health has awarded Winston a grant under the Small Business Innovation Research program supporting the development of Civamide, a proprietary TRPV-1 receptor modulator, for the treatment of postherpetic neuralgia of the trigeminal nerve.

9 Apr 2012

On the campaign trail, it seems everyone has critics

According to reports, the Obama administration continues to face stiff criticism from Catholic leaders over its contraception policies. Meanwhile, GOP presidential hopeful Mitt Romney has among his health policy advisers two people who are on the record in their opposition to the health he signed while governor of Massachusetts.

9 Apr 2012

Researchers question wisdom of blocking DP1 in patients prone to cardiovascular disease

Niacin, or vitamin B3, is the one approved drug that elevates "good" cholesterol (high density lipoprotein, HDL) while depressing "bad" cholesterol (low density lipoprotein , LDL), and has thereby attracted much attention from patients and physicians. Niacin keeps fat from breaking down, and so obstructs the availability of LDL building blocks.

9 Apr 2012

Heart cells starved of nutrients less likely to be damaged during ischemia, reperfusion

Heart cells starved of nutrients are less likely to be damaged during periods of decreased blood flow and sudden influxes of blood, known as ischemia and reperfusion, and are also less likely to get out of synch with their cellular neighbors, the damaging phenomenon called arrhythmia.

9 Apr 2012

MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced that investigators at The University of Texas MD Anderson Cancer Center Department of Breast Medical Oncology have initiated a phase 1/2 study combining Syndax's lead product entinostat with lapatinib ditosylate (Tykerb) in patients with locally recurrent or distant relapsed metastatic breast cancer previously treated with trastuzumab (Herceptin).

9 Apr 2012

Kodak withdraws plan to end health benefits for Medicare-eligible retirees

In the midst of bankruptcy proceedings, Kodak withdrew a motion to end these health benefits and will instead create a reitrees commitee to examine issues of medical and survivor benefits. Meanwhile, AT&T contract negotiations continue -- with health care premiums and copayments among the issues in play.

9 Apr 2012

Derma Sciences closes underwritten registered direct offering

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that it closed an underwritten registered direct offering of 2,125,000 shares of common stock at a price of $9.25 per share on April 5, 2012.

9 Apr 2012

Spacelabs Healthcare receives FDA marketing clearance for new compact monitor

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received clearance under Section 510(k) from the U.S. Food and Drug Administration to market qube, a new compact monitor.

9 Apr 2012

Nuron Biotech licenses DNA amyloid beta 42 vaccine for AD

Nuron Biotech, Inc. today announced it has licensed from VITRUVIAN BioMedical, Inc. a gene-based (DNA) amyloid beta 42 (Aβ42) vaccine in preclinical development for Alzheimer's disease (AD).

9 Apr 2012

NINDS awards NeuroSigma Phase I grant to develop TFN-covered stents

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has been awarded a Phase I NIH-STTR grant from the National Institute of Neurological Disorders and Stroke (NINDS) for the further development of its Thin-Film Nitinol (TFN)-covered stent for the potential treatment of brain aneurysms.

9 Apr 2012

Ampio submits pre-IND package on Zertane to FDA

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.

9 Apr 2012

Medical News

New text messaging program to manage diabetes

Blog posts respond to Melinda Gates' TEDxChange presentation

Chemotherapy based on individual genomes and genomes of tumors

Idaho's adoption of NPLEx to block illegal methamphetamine sales receives praise

A step closer to correcting unhealthy gene mutations with diet

States count health law dollars, brace for back-ups if overhaul struck down

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

Japanese MHLW approves Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System

Five significant genetic associations for hypothyroidism found

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN

On the campaign trail, it seems everyone has critics

Researchers question wisdom of blocking DP1 in patients prone to cardiovascular disease

Heart cells starved of nutrients less likely to be damaged during ischemia, reperfusion

MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer

Kodak withdraws plan to end health benefits for Medicare-eligible retirees

Derma Sciences closes underwritten registered direct offering

Spacelabs Healthcare receives FDA marketing clearance for new compact monitor

Nuron Biotech licenses DNA amyloid beta 42 vaccine for AD

NINDS awards NeuroSigma Phase I grant to develop TFN-covered stents

Ampio submits pre-IND package on Zertane to FDA

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News